Polaris Insight Center, Ketamine Assisted Psychotherapy
- Ketamine Therapy
Read the Ketamine Therapy guide for the educational context behind this treatment category.
San Francisco, CA
Searching for ketamine infusion therapy in the Bay Area, CA, means comparing both the treatment offered and the trip home. This page narrows that regional search to San Francisco specifically, since a general Bay Area search commonly mixes several cities with very different commutes and parking. San Francisco has ketamine services in the Van Ness Avenue medical office corridor around Jackson Street, while Berkeley offers options across the Bay. Check the treatment address before assuming a Bay Area listing is in San Francisco itself. Travel from the East Bay involves the Bay Bridge, while Marin patients approach through the Golden Gate Bridge corridor, so plan for traffic and an adult escort after treatment.
For intravenous ketamine therapy in San Francisco, look for a medical office or infusion suite with clinical monitoring and a named prescribing clinician. Confirm that the location provides IV infusions rather than only nasal esketamine or ketamine-assisted psychotherapy. An initial assessment should review your diagnosis, previous treatment, medications, blood pressure, and medical history. Ask who administers the medication, who supervises recovery, and how follow-up will track symptoms and coordinate with your existing mental health care.
Before booking, request the prescriber's credentials and ask where the medication comes from, including whether it is compounded. Get written information about side effects, emergency procedures, and whom to contact after leaving. Ask how the plan changes if symptoms do not improve, and request a quote separating the assessment, medication, administration, monitoring, psychotherapy, and follow-up. IV ketamine for depression is an off-label use, meaning it lacks FDA approval for that purpose, and is commonly cash pay; evidence for some other psychiatric uses remains limited.
Organic listing order on Regenerated.com cannot be bought. Featured placements are labeled and limited in number, while Verified indicates credential checks rather than advertising spend. Patients can use Regenerated.com free of charge, and inclusion in the directory is not an endorsement.
The national ketamine therapy hub explains the mechanism and broader evidence, while this page helps you compare local access and care arrangements. To understand the listings and badges, read How to read a Regenerated city hub and Featured vs Verified vs organic.
Regulatory context
Ketamine is a DEA Schedule III controlled substance, FDA-approved as a dissociative anesthetic and used off-label for treatment-resistant depression, PTSD, and chronic pain. The FDA approved esketamine (Spravato) in 2019 for treatment-resistant depression under a Risk Evaluation and Mitigation Strategy (REMS) program that requires in-office administration at certified sites. MDMA-assisted therapy remains Schedule I; the FDA issued a Complete Response Letter in August 2024 to Lykos Therapeutics on its MDMA new drug application. Psilocybin is Schedule I and holds FDA Breakthrough Therapy designation through sponsors such as Compass Pathways and Usona, but has not received FDA approval. Oregon Measure 109 (passed 2020, operational 2023) created a state psilocybin service center framework, and Colorado Proposition 122 (2022) authorized regulated healing centers.
California enforces federal DEA scheduling. The Medical Board of California investigates prescriber misconduct, including ketamine diversion and inadequate patient monitoring. Several high-profile California ketamine-related deaths (including Matthew Perry's 2023 overdose) have intensified board scrutiny of clinic practices. DEA enforcement targets compounding, diversion, and Ryan Haight Act telehealth compliance.
Explore nearby
Available here
Explore statewide
Ketamine Therapy in CaliforniaNationwide
Ketamine Therapy clinics across the US